Especially in pancreatic cancer cells, there is a cross-talk and activation between PI3K/AKT and NF-κB which results in multidrug resistance through the stimulation of Cyclin D1 to accelerate cell progression and tumor growth leading to drug resistance. Here, AKT1 is linked to familial pancreatic carcinoma.